6 material Form 8-K filings that 6 companies we cover made with the SEC in May 2023, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
On May 21, 2023, Krystal Biotech agreed to sell 1,729,729 shares of common stock to institutional investors at $92.50 per share, for an aggregate purchase price of approximately $160 million before offering expenses. The company plans to use the proceeds for commercialization of VYJUVEK, its clinical pipeline, business development, and working capital, and expects the sale to close on May 22, 2023. The new shares add to the company's outstanding share count, which dilutes existing shareholders, while the company says the funds should support operations through the end of 2026.
1,729,729 shares of common stock to be sold at $92.50 per share, for approximately $160 million in gross proceeds before offering-related expenses
Agreement dated May 21, 2023; closing expected May 22, 2023, subject to customary conditions
Financing led by Avoro Capital Advisors and Redmile Group, LLC, with participation from Braidwell LP and Frazier Life Sciences
Company agreed to file a registration statement for resale of the shares within 60 days of closing
Life360 reported first-quarter 2023 revenue of $68.1 million, up 34% from a year earlier, and a net loss of $14.1 million, narrower than the $25.2 million loss a year ago. The company reiterated its calendar 2023 guidance and said it reached positive Adjusted EBITDA a quarter ahead of expectations. It also named Lauren Antonoff chief operating officer, and the departure date of President CJ Prober was moved to July 7, 2023.
Q1 2023 revenue of $68.1 million, up 34% year over year; subscription revenue of $51.7 million versus $33.1 million a year earlier
Net loss of $14.1 million versus $25.2 million in Q1 2022; Adjusted EBITDA of $0.5 million versus a loss of $13.7 million
CY23 guidance reiterated, including consolidated revenue of $300 million to $310 million
Lauren Antonoff appointed Chief Operating Officer effective May 2, 2023, with a $450,000 base salary; CJ Prober's departure date changed to July 7, 2023
International Bancshares Corporation reported net income of $101.6 million, or $1.63 per diluted share, for the three months ended March 31, 2023, up from $53.5 million, or $0.84 per diluted share, a year earlier. The company attributed the increase mainly to higher net interest income, including interest on its investment portfolio, funds held at the Federal Reserve Bank, and loans. Total assets and deposits were lower at March 31, 2023 than at December 31, 2022.
Net income for Q1 2023 was $101.6 million, up 90% from $53.5 million in Q1 2022
Diluted EPS was $1.63, compared with $0.84 a year earlier, an increase of 94%
Total assets were $15.1 billion at March 31, 2023, versus $15.5 billion at December 31, 2022
Deposits were $12.3 billion at March 31, 2023, versus $12.7 billion at December 31, 2022
Curtiss-Wright reported first quarter 2023 sales of $631 million, up 13% from a year earlier, and reported diluted earnings per share of $1.48 versus $1.05. The company maintained its full-year 2023 adjusted guidance, including adjusted diluted EPS of $8.65 to $8.90, which signals that management expects its growth to continue.
Sales of $631 million, up 13%; new orders of $718 million, up 13%
Reported diluted EPS of $1.48 vs. $1.05; adjusted diluted EPS of $1.53, up 17%
Full-year 2023 guidance maintained: adjusted sales of $2,655 million to $2,710 million and adjusted diluted EPS of $8.65 to $8.90
Reported free cash flow was negative $102 million, compared with negative $135 million a year earlier
United States Lime & Minerals reported first quarter 2023 revenue of $66.8 million, up 31.2% from $50.9 million a year earlier, and net income of $17.1 million ($3.00 per share diluted) versus $8.7 million ($1.53 per share). Management said it expects continued pressure on lime and limestone production costs and that recessionary concerns could affect future demand.
Revenue was $66.8 million, up $15.9 million or 31.2% from $50.9 million in Q1 2022, driven by higher average selling prices and sales volumes.
Gross profit was $24.0 million, up 65.8% from $14.5 million; SG&A expenses rose 14.2% to $4.2 million.
Net income was $17.1 million ($3.00 per share diluted), compared with $8.7 million ($1.53 per share diluted) in Q1 2022.
The Board declared a regular quarterly cash dividend of $0.20 per share, payable June 16, 2023 to shareholders of record on May 26, 2023.
New York Mortgage Trust reported first-quarter 2023 net income attributable to common stockholders of $10.5 million, or $0.12 per basic share, compared with a loss of $84.3 million a year earlier. Net interest income fell to $17.8 million from $37.0 million, and book value per common share was $12.95 at March 31, 2023, down from $13.27 at December 31, 2022. The filing header names Adamas Trust (ADAM), but the attached press release and financial tables are for New York Mortgage Trust (Nasdaq: NYMT), so this summary uses those figures.
Net income attributable to common stockholders was $10.5 million ($0.12 basic per share) for the quarter ended March 31, 2023, versus a loss of $84.3 million ($0.89 per share) a year earlier
Total net interest income was $17.8 million, down from $37.0 million in the first quarter of 2022
Book value per common share was $12.95 at March 31, 2023, versus $13.27 at December 31, 2022
The company upsized its common stock repurchase program to $246.0 million and effected a one-for-four reverse stock split on March 9, 2023
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.